Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...

Acurx Pharmaceuticals (Nasdaq: ACXP) (Acurx or the Company), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections ...

Rodents fed a diet high in soluble fiber showed improved resistance to a microorganism that causes diarrhea and can be fatal ...

Faecal transplants can boost the immune systems of patients with advanced cancer, improving their response to immunotherapy.

Objective: To describe emergent therapies, such as rifaximin, nitazoxanide, intravenous immunoglobulin (IVIG), tinidazole, tolevamer, and the possible use of a vaccine, in Clostridium difficile ...

Chandigarh: Despite the high burden of Hepatitis C in Punjab, a significant proportion of patients discontinue treatment due to a lack of counselling, revealed a joint study conducted by the ...

Concerning treatment, supervised exercise-based programmes preferred over passive modalities as it stimulates the recovery of functional joint stability. Surgery should be reserved for cases that do ...

C. difficile infection causes severe diarrhea, which can lead to sepsis (generalized infection) and even death. Many strains are resistant to existing drugs, making treatment difficult.

was introduced to help battle long delays for treatment within B.C. An average of about 50 British Columbians a week received care in Bellingham at the program's peak in the fall of 2023.

The bacterium Clostridium difficile — otherwise known as C. diff — spreads within intensive care units more than three times as much as previously thought, according to a study published on ...

The bacterium Clostridium difficile – commonly called C. diff – spreads within intensive care units more than three times as much as previously thought, researchers reported in JAMA Network Open.